Inactivation of the INK4A/ARF locus frequently coexists with TP53 mutations in non-small cell lung cancer

Oncogene

Volumn 18, Issue 43, 1999, Pages 5843-5849

  Sanchez Cespedes, Montserrat ^a   Reed, Andre L ^a   Buta, Martin ^a   Wu, Li ^a   Westra, William H ^a   Herman, James G ^a   Yang, Stephen C ^a   Jen, Jin ^a   Sidransky, David ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Non small cell lung cancer; p14(ARF) inactivation; p16 inactivation; p53 gene mutations

Indexed keywords

MICROSATELLITE DNA; PROTEIN P16; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DELETION MUTANT; DNA METHYLATION; EXON; GENE INACTIVATION; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

CARCINOMA, NON-SMALL-CELL LUNG; CYCLIN-DEPENDENT KINASE INHIBITOR P16; HUMANS; LUNG NEOPLASMS; MUTATION; PROTEINS; TUMOR SUPPRESSOR PROTEIN P14ARF; TUMOR SUPPRESSOR PROTEIN P53;

MARTES PENNANTI;

EID: 0033592584     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1203003     Document Type: Article

References (24)

1. Arhrendt SA, Halachmi S, Chow JT, Wu L, Halachmi N, Yang SC, Wehage S, Jen J and Sidransky D. (1999). Proc. Natl. Acad. Sci. USA, 96, 7382-7387.
2. Cairns P, Mao L, Merlo A, Lee DJ, Schwab D, Eby Y, Tokino K, van der Riel P, Blaugrund JE and Sidransky D. (1994). Science. 265, 415-417.
3. Cairns P, Polascik TJ, Eby Y, Tokino K, Califano J, Merlo A, Mao L, Herath J, Jenkins R, Westra W, Rutter JL, Bucker A, Gabrielson E, Tockman M, Cho KR, Hedrick L, Bova SG, Isaacs W, Koch W, Schwab D and Sidransky D. (1995). Nature Genet., 11, 210-212.
4. Chin L, Pomerantz J and DePinho RA. (1998). Trends Biochem. Sci., 23, 291-296.
5. Gazzeri S, Della Valle V, Chaussade L, Brambilla C, Larse CJ and Brambilla E. (1998). Cancer Res., 58, 3926-3931.
6. Herman JG, Graff JR, Myohanen S, Nelkin BD and Baylin SB. (1996). Proc. Natl. Acad. Sci. USA, 93, 9821-9826.
7. Kamijo T, Zindy F, Roussel MF, Quelle DE, Downing JR, Ashmun RA, Grosreld G and Sherr CJ. (1997). Cell, 91, 649-654.
8. Kinoshita I, Dosaka-Akita H, Mishina T, Akie K, Nishi M, Hiroumi H, Hommura F and Kawakami Y. (1996). Cancer Res., 56, 5557-5562.
9. Ko LJ and Prives C. (1996). Genes Dev., 10, 1054-1072.
10. Kratzke R, Shimizu E and Kaye F. (1992). Cancer Treat. Res., 63, 61-85.
11. Kratzke RA, Greatens TM, Rubins JB, Maddaus MA, Niewoehner DE and Niebans GA. (1996). Cancer Res., 56, 3415-3420.
12. Larsen CJ. (1996). Oncogene, 16, 2041-2044.
13. Ling L, Dilworth D, Gao L, Monzon J, Summers A, Lassam N and Hogg D. (1999). Nature Genet., 21, 128-132.
14. Mao L, Merto A, Bedi G, Shapiro GI, Edwards CD, Barren JR and Sidransky D. (1995). Cancer Res., 55, 2995-2997.
15. Mark HDC and Jones P. (1998). Cancer Res., 55, 5348-5353.
16. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB and Sidransky D. (1995). Nature Med., 1, 686-692.
17. Mitsudomi T and Takahashi T. (1996). Japan. J. Cancer Chem., 23, 990-996.
18. Munro J, Scott FJ, Vousden KH, Peters G and Parkinson EK. (1999). Cancer Res., 59, 2516-2521.
19. Reed AL, Califano J, Cairns P, Westra WH, Jones RM, Koch W, Ahrendt S, Eby Y, Sewell D, Nawroz H, Bartek J and Sidransky D. (1996). Cancer Res., 56, 3630-3633.
20. Robertson KD and Jones PA. (1998). Mol. Cell Biol., 18, 6457-6473.
21. Sidransky D. (1996). Curr. Biol., 6, 523-525.
22. Sidransky D, Von Eschenbach A, Tsai YC, Jones P, Summerhayes I, Marshall F, Paul M, Green P, Hamilton SR, Frost P, et al., (1991). Science, 252, 706-709.
23. Stone S, Jiang P, Dayananth P, Tavtigian SV, Katcher H, Parry D, Peters G and Kamb A. (1995). Cancer Res., 5, 2988-2994.
24. Van der Riel P, Nawroz H, Hruban RH, Corio R, Tokino K, Koch W and Sidransky D. (1994). Cancer Res., 54, 1156-1158.